Article
Tumor glycosylation engages CD301b-mediated myeloid regulation in breast cancer
2026-05-05
Abstract excerpt
<title>Abstract</title> <p> Aberrant tumor glycosylation can alter immune recognition; however, the specific influence of glycan-lectin interactions on tumor progression remains poorly understood. Here, we identify the C-type lectin receptor CD301b (encoded by <italic>Mgl2</italic> ) as a regulator of immune activity within the breast tumor microenvironment (TME) and identify a cross-species myeloid regulatory...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 89a0af2d-02bd-5cea-82c7-78f36d6a17b8
- DOI
- 10.21203/rs.3.rs-9347231/v1
